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Protective effect of magnesium on the endothelial
function mediated by endothelium-derived hyperpolarizing
factor in coronary arteries during cardioplegic arrest in a
porcine model
Qin Yang, MD, MPH,a Yao-Chung Liu, MD,a Wei Zou, MD,a Anthony P. C. Yim, MD,a and Guo-Wei He, MD, PhDa,b
Objectives: Hyperkalemia in cardioplegia impairs the function me-
diated by endothelium-derived hyperpolarizing factor. This study
examined the effect and mechanism of magnesium ion on the
relaxation mediated by endothelium-derived hyperpolarizing factor.
Methods: In the isometric force study, porcine coronary microar-
teries in a myograph (diameter 200-450 m) were incubated in
Krebs solution (subgroups Ia, IIa, and IIIa), potassium ion (20
mmol/L, subgroups Ib, IIb, and IIIb), magnesium ion (16 mmol/L,
subgroups Ic, IIc, and IIIc), or potassium ion plus magnesium ion
(subgroups Id, IId, and IIId) for 1 hour at 37°C in group I or II,
followed by washout for 45 minutes in group III (n  8). Relax-
ation to bradykinin (groups I and III) or sodium nitroprusside
(group II) in U46619-stimulated contraction was established. In the electrophysi-
ologic study, the membrane potentials of single smooth muscle cells of arteries were
measured by microelectrode after superfusion with the previously described solu-
tions (subgroups IVa-IVc).
Results: In group I, 20-mmol/L potassium ion greatly reduced the bradykinin-
induced relaxation (35.0%  4.9% vs 86.0%  5.3%, P  .001), which was
significantly restored by magnesium ion (51.9%  4.0%, P  .017). In groups II
and III, the bradykinin- or nitroprusside-induced relaxation had no significant
differences. In group IV, potassium ion depolarized the smooth muscle and de-
creased the bradykinin-induced hyperpolarization (72.0  1.5 vs 61.7  0.7
mV, n  7, P  .001), which was significantly restored by magnesium ion
(68.0  2.5 mV vs 72.5  1.5 mV, n  6, P  .029).
Conclusions: Magnesium ion, either alone or added to hyperkalemic solutions,
preserves or helps to restore the endothelial function mediated by endothelium-
derived hyperpolarizing factor. The mechanism is related to preservation of the
membrane hyperpolarization and reversal of the potassium-induced membrane
depolarization of the smooth muscle cell.
Depolarizing cardioplegia is widely used in cardiac surgery to arrestthe heart and protect it from subsequent ischemia-reperfusioninjury.1 The major depolarizing agent in these cardioplegic solu-tions is potassium at high concentrations (hyperkalemia), usually10 to 20 mmol/L.1 Previous studies have shown that hyperkalemiacauses damage to arterial endothelial function.2-4
Endothelium exerts an important modulatory effect on vascular tone. Endothe-
lium-dependent relaxation is known to be caused by a variety of endothelium-
derived relaxing factors. These are endothelium-derived nitric oxide, prostacyclin
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(PGI2), and endothelium-derived hyperpolarizing factor
(EDHF).5,6 Because of the complexity of endothelial func-
tion, it is necessary to study the functions of individual
endothelium-derived relaxing factors to find the “perfect”
method to preserve the endothelium during cardiac surgery.
EDHF-mediated endothelial function plays an important
role in the coronary circulation as the backup for nitric
oxide, particularly in the coronary microarteries.7
On the basis of these considerations, our laboratory has
demonstrated that hyperkalemia alters EDHF-mediated re-
laxation and hyperpolarization (the electrophysiologic basis
of mechanical relaxation) in both porcine and human coro-
nary conduit arteries.6,8,9 Most recently, we have found that
this is also true in porcine coronary microarteries.10
Apart from potassium, magnesium is another important
ion in either crystalloid11 or blood12,13 cardioplegia. For
example, St Thomas’ Hospital solution contains 16-mmol/L
magnesium ion. It has been reported that addition of mag-
nesium to the cardioplegic solution is beneficial in myocar-
dial protection.11 Moreover, in blood cardioplegia, magne-
sium ion is also suggested to be supplemented to relieve
cardiac injury.12,13 Although much is known about magne-
sium’s favorable effect on cardiac myocytes, little is known
about its effect on endothelial function. Although there is
evidence that hypermagnesemic cardioplegia is superior to
hyperkalemic cardioplegia in preserving endothelium-
dependent relaxation in porcine coronary microvessels,14
the effects of magnesium ion on EDHF-mediated relaxation
and hyperpolarization have not been reported. We have
previously observed that vascular tone increases during
incubation with potassium ion at 16 to 20 mmol/L but
remains almost normal during incubation with St Thomas
Hospital cardioplegia.15 We therefore hypothesized that the
normal vascular tone during incubation with the St Thomas
Hospital cardioplegia solution is due to the reversal effect of
the magnesium ion contained in that solution and thus that
magnesium ion may have a protective effect on EDHF-
mediated relaxation and hyperpolarization. To test this hy-
pothesis, this study was designed to investigate the effects
of magnesium ion and its interaction with potassium ion on
EDHF-mediated relaxation and hyperpolarization induced
by bradykinin in porcine coronary arteries.
Material and Methods
Relaxation Studies
Fresh porcine hearts collected from a local slaughterhouse were
placed in a container filled with cold Krebs solution and immedi-
ately transferred to the laboratory. Once a heart was received,
intramyocardial coronary microarteries (usually the tertiary
branches of the left anterior descending artery, diameter 200-450
m) were carefully dissected and removed under a microscope.
The vessels were cleaned of fat and connective tissue and cut into
cylindrical rings 2 mm in length under a microscope. The Krebs
solution was aerated with a gas mixture of 95% oxygen and 5%
carbon dioxide at 37°C and had the following composition: 118.4-
mmol/L sodium chloride, 4.7-mmol/L potassium chloride, 1.2-
mmol/L magnesium sulfate, 1.2-mmol/L potassium phosphate,
25-mmol/L sodium hydrogen carbonate, 11.1-mmol/L ()-
glucose, and 2.5-mmol/L calcium chloride. This solution contains
the following final ionic concentrations: 143.4-mmol/L sodium
ion, 5.9-mmol/L potassium ion, 2.5-mmol/L calcium ion, 1.2-
mmol/L magnesium ion, 128.7-mmol/L chloride ion, 25-mmol/L
hydrogen carbonate ion, 1.2-mmol/L sulfate ion, 1.2-mmol/L
phosphate ion, and 11.1-mmol/L glucose.
During the preceding procedure, the endothelium was inten-
tionally preserved by cautiously dissecting and mounting the rings.
After the rings were mounted in a four-channel myograph (model
610A; J.P. Trading, Aarhus, Denmark), a previously described
method6,10 was used to normalize vascular rings under a condition
simulating the transmural pressure encountered in vivo in the
coronary microartery. Briefly, the artery rings were progressively
stretched until the passive transmural pressure reached 100 mm
Hg. The internal circumference was then set to a normalized value,
estimated to be equivalent to 90% of the circumference at a passive
transmural pressure of 100 mm Hg. This pressure was maintained
throughout the experiments.
Protocols. All rings were equilibrated for 30 minutes
before and after normalization. The following protocols
were used.
GROUP I (N 8 IN EACH SUBGROUP). Effect of potassium ion (20
mmol/L) or magnesium ion (16 mmol/L) on endothelium-derived
hyperpolarizing factor–mediated relaxation in microarteries.
Four rings taken from the same artery were allocated into four
groups. The arterial rings were incubated with four different so-
lutions for 1 hour at 37°C: subgroup Ia, Krebs solution as a control;
subgroup Ib, potassium ion (20 mmol/L); subgroup Ic, magnesium
ion (16 mmol/L); and subgroup Id, potassium ion (20 mmol/L)
plus magnesium ion (16 mmol/L). In these high-potassium or
high-magnesium solutions, sodium was replaced with the equiva-
lent potassium or magnesium form. In 20-mmol/L potassium ion
solution, 14-mmol/L sodium chloride was replaced with 14-
mmol/L potassium chloride. In 16-mmol/L magnesium ion solu-
tion, 29.6-mmol/L sodium chloride (14.8  2) was replaced with
14.8-mmol/L magnesium sulfate. In the combined 20-mmol/L
potassium ion and 16-mmol/L magnesium ion solution, 43.6-
mmol/L sodium chloride (14  14.8  2) was replaced with
14-mmol/L potassium chloride and 14.8-mmol/L magnesium sul-
fate. The osmolarity therefore remained unchanged.
Inhibitors for PGI2 and nitric oxide were then added into the
chamber. They were as follows: indomethacin (7 mol/L, a cyclo-
oxygenase inhibitor), NG-nitro-L-arginine (L-NNA, 300 mol/L, a
nitric oxide synthase inhibitor), and oxyhemoglobin (20 mol/L, a
nitric oxide scavenger). The arteries were contracted with U46619 in
varying amounts (8.4 log mol/L for subgroup Ib,7.5 log mol/L
for subgroups Ia and Id, and 7 log mol/L for subgroup Ic) to
reach a similar contraction force, because the arteries in subgroups
Ib and Id were already contracted with 20-mmol/L potassium ion.
Subsequently, concentration-relaxation curves were established for
bradykinin (10 to 6.5 log mol/L) in the presence of indometh-
acin, L-NNA, and oxyhemoglobin. This relaxation was the EDHF-
mediated relaxation, because the production of both nitric oxide
and PGI2 were inhibited.7
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GROUP II (N  6 IN EACH SUBGROUP). Effect of potassium ion
(20 mmol/L) or magnesium ion (16 mmol/L) on sodium nitro-
prusside–induced relaxation in microarteries.
Four rings taken from the same artery (subgroups IIa-IId) were
incubated with different solutions as in group I. After 1 hour,
sodium nitroprusside (SNP, 9 to 4 log mol/L) was cumula-
tively applied to induce relaxation in the arteries previously con-
tracted with U46619 (8.4 to 7 log mol/L, see group I).
GROUP III (N  8 IN EACH SUBGROUP). Effect of potassium ion
(20 mmol/L) or magnesium ion (16 mmol/L) on endothelium-
derived hyperpolarizing factor–mediated relaxation in microarter-
ies after washout.
The protocol was similar to that in group I. Four rings taken
from the same artery were allocated into four subgroups. The
arterial rings were incubated with four different solutions for 1
hour at 37°C: subgroup IIIa, Krebs solution as a control; subgroup
IIIb, 20-mmol/L potassium ion; subgroup IIIc, 16-mmol/L mag-
nesium ion; and subgroup IIId, 20-mmol/L potassium ion plus
16-mmol/L magnesium ion. In these high-potassium ion or high-
magnesium ion solutions, sodium was replaced with the equivalent
potassium or magnesium form as described previously. One hour
later, the solutions were replaced with the normal Krebs solution,
and inhibitors for PGI2 and nitric oxide were added into the
chamber. The washout time was 45 minutes. The arteries were
contracted with U46619 (8.0 log mol/L). Subsequently, concen-
tration-relaxation curves were then established for bradykinin
(10 to6.5 log mol/L) in the presence of indomethacin, L-NNA,
and oxyhemoglobin.
In another group of experiments, arterial rings (n  8) were
denuded of endothelium mechanically to examine the endothelium
dependence of the bradykinin-induced relaxation.
Electrophysiological Studies (Cellular Membrane
Potential Measurement)
Porcine epicardial coronary arteries were dissected out, and a
segment (3-4 mm) was carefully slit along the longitudinal axis.
The strips were pinned down by stainless steel pins, inner side
upward, on the bottom of a 2-mL organ bath. The strip of the
coronary artery was superfused with Krebs solution at the rate of
2 mL/min, aerated with mixture of 95% oxygen and 5% carbon
dioxide at 37°C. After 60 minutes of equilibrium, a glass micro-
electrode filled with 3-mol/L potassium chloride (tip resistance
40-80 M) was inserted into a smooth muscle cell from the
endothelial side.6,7,9 The electrical signals were amplified by
means of a microelectrode amplifier electrometer (ELECTRO 705;
World Precision Instruments, Inc, Sarasota, Fla). The output sig-
nals were displayed on an oscilloscope (2120 B; World Precision
Instruments) and recorded by a computer that installed Picoscope
program (Pico Technology Limited, Hardwick, United Kingdom).
The criteria of impaling cells were a sudden negative change in
voltage followed by a stable negative voltage for more than 1
minute as well as an instantaneous return to the previous voltage
level on dislodgment of the microelectrode.6,7,9,16-18
Protocols. After equilibrium for 60 minutes, a microelectrode
was inserted into the smooth muscle cell and the baseline (resting)
membrane potential was recorded. In the presence of indomethacin
(7 mol/L) and L-NNA (300 mol/L) for 30 minutes, concentra-
tion-response (hyperpolarization) curves were established for bra-
dykinin (10 to 6.5 log mol/L) as a control. The vascular strip
was washed with normal Krebs solution for 30 minutes to restore
the baseline (resting) membrane potential and then superfused with
one of the three modified Krebs solutions containing 20-mmol/L
potassium ion, 16-mmol/L magnesium ion, or 20-mmol/L potas-
sium ion plus 16-mmol/L magnesium ion (final concentration). In
these solutions, sodium was replaced with the equivalent potas-
sium or magnesium form as described previously to maintain the
final osmolarity of the solution. The protocols were as follows:
subgroup IVa, superfusion with Krebs solution containing 20-
mmol/L potassium ion for 1 hour; subgroup IVb, superfusion with
Krebs solution containing 16-mmol/L magnesium ion for 1 hour;
and subgroup IVc, superfusion with Krebs solution containing
20-mmol/L potassium ion and 16-mmol/L magnesium ion for 1
hour.
The vessel was then washed within 30 minutes, and the con-
centration–response (hyperpolarization) curve for bradykinin was
established with the presence of indomethacin (7mol/L) and
L-NNA (300 mol/L). Another group of coronary arterial strips
were used as the time control for the bradykinin-induced hyper-
polarization.
In separate experiments, coronary arteries (n  6) were de-
nuded of endothelium mechanically to examine the endothelium
dependence of the bradykinin-induced hyperpolarization.
Data Analysis
Relaxation was expressed as the percentage decrease in isometric
force induced by U46619. The effective concentration of bradykinin
that caused 50% of maximal relaxation was defined as the EC50.
The EC50 was determined from each concentration-relaxation
curve by a logistic, curve-fitting equation: E  MAP/ (AP  KP),
where E is response, M is maximal relaxation, A is concentration,
K is EC50, and P is the slope parameter. From this fitted equation,
the mean ( SEM) EC50 was calculated for each group.
Statistical Analysis
Data were expressed as mean  SEM and were analyzed with
analysis of variance (ANOVA) followed by the Scheffe´ F test or
t test as appropriate.
Drugs
Drugs used and their sources were as follows: bradykinin, l-NNA,
and indomethacin, Sigma Chemical Co (St Louis, Mo); and
U46619, Cayman Chemical (Ann Arbor, Mich). L-NNA (dissolved
in distilled water) and indomethacin (dissolved in ethanol) were
stored at 4°C. The solution of U46619 was held frozen until re-
quired.
Results
Relaxation Studies
Arterial tone during incubation. The arterial tone val-
ues during the incubation with different ions showed
marked differences. Compared with a slight increase in tone
in the control preparation, 20-mmol/L potassium ion caused
a significant contraction (10.4  1.1 mN vs 1.0  0.2 mN,
95% confidence interval [CI] 11.9 to 6.9 mN, P 
.001), whereas incubation with magnesium ion slightly re-
duced the tone (0.5  0.1 mN vs 1.0  0.2 mN, 95% CI
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1.0 to 4.0 mN, P  .378). The effect on the tone of
20-mmol/L potassium ion plus 16-mmol/L magnesium ion
was between the control value and the value achieved with
16-mmol/L magnesium ion alone (Figure 1).
Comparison of precontraction. In the group I arteries,
magnesium ion markedly depressed the contractile response
to U46619, whereas potassium ion caused a significant con-
traction before addition of U46619. To make the subsequent
relaxations comparable, we intended to induce a compara-
ble precontraction by using different concentrations of
U46619, ranging from 8.4 log mol/L to 7 log mol/L.
However, there was still a difference among the 4 subgroups
of group I (P  .001 by ANOVA), although the differences
between the control subgroup (subgroup Ia) and the other
subgroups did not reach statistical significance according to
the post hoc test Scheffe´ F test (Figure 2, A). Further, in
subgroup Ib the contraction induced by potassium ion and
then U46619 was higher than that in subgroups Ic (18.0 2.2
mN vs 6.0  1.0 mN, 95% CI 5.1-18.9 mN, P  .001 by
Scheffe´ F test) and Id (18.0  2.2 mN vs 10.2  1.4 mN,
95% CI 1.0-14.7 mN, P  .021 by Scheffe´ F test; Figure 2,
A). However, this difference disappeared when the incu-
bated solution was washed out (group II, P  .733; Figure
2, B).
Effects of 20-mmol/L potassium ion, 16-mmol/L mag-
nesium ion, or both on bradykinin-induced relaxation
(group I). In group I, exposure to 20-mmol/L potassium
ion (subgroup Ib) greatly reduced the bradykinin-induced
EDHF-mediated relaxation (35.0%  4.9% vs 86.0% 
5.3%, 95% CI 31.7%-70.2%, P  .001). Magnesium ion
(subgroup Ic) slightly reduced this relaxation, but without
statistical significance (P  .243). Most important, the
addition of magnesium ion to a hyperkalemic solution (sub-
Figure 1. Change in resting force in porcine coronary microarter-
ies during incubation with Krebs solution (control, subgroup Ia,
filled circles) or solution containing 20-mmol/L potassium ion
(subgroup Ib, open circles), 16-mmol/L magnesium ion (subgroup
Ic, filled squares), or 20-mmol/L potassium ion plus 16 mmol/L
magnesium ion (subgroup Id, open squares). Four rings taken from
same microartery were allocated in four chambers of myograph,
n  8 in each group. Triple asterisk indicates P < .001 vs Krebs
solution by ANOVA and Scheffe´ F test.
Figure 2. Mean contraction force response to U46619 (range 8 to
7 log mol/L, see Methods section) after exposure to Krebs
solution (control, subgroup Ia) or solution containing 20-mmol/L
potassium ion (subgroup Ib, K20), 16-mmol/L magnesium ion (sub-
group Ic, Mg16), or potassium ion plus magnesium ion (subgroup
Id, K20Mg16) for 1 hour in groups I (A) and III (B). Four rings
taken from same microartery were allocated in four chambers of
myograph, n  8 in each group. A, P < .001 among 4 subgroups
by ANOVA, but P > .05 for subgroups Ib, Ic, and Id compared with
Krebs solution (control subgroup) by ANOVA and Scheffe´ F test. B,
P > .05 among 4 subgroups.
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group Id) led to significant recovery of the reduction of the
relaxation induced by potassium ion alone (51.9%  4.0%
vs 35.0%  4.9%, 95% CI 30.4% to 3.4%, P  .017;
Table 1 and Figure 3, A).
In group III, the influence of 20-mmol/L potassium ion
(subgroup IIIb) on the bradykinin-induced EDHF-mediated
relaxation was reduced to minimum by washout for 45
minutes, although there was still a slight reduction of the
relaxation in subgroup IIIb relative to the control subgroup
(subgroup IIIa, 73.8%  8.9% vs 87.1%  7.0%, 95% CI
11.1% to 37.5%, P  .2; Figure 4).
With respect to EC50, after incubation with 20-mmol/L
potassium ion, the significantly reduced relaxation in 3 of 8
arteries caused an EC50 so high that it could not be calcu-
lated from the curve-fitting equation (see Methods section).
Similarly, the EC50 could not be calculated in 3 rings
incubated with 20-mmol/L potassium ion plus 16-mmol/L
magnesium ion, and in the remaining 5 rings the EC50 was
slightly higher than that in the control subgroup (P  .052
vs by unpaired t test; Table 1). These results imply that
incubation with 20-mmol/L potassium ion either with or
without magnesium ion significantly decreased the sensitiv-
ity of the artery to bradykinin (increased EC50). In group III,
there were no differences between the control subgroup and
other subgroups with respect to the EC50.
In the 8 arteries with the endothelium denuded, the
bradykinin-induced relaxation was abolished.
Effects of 20-mmol/L potassium ion, 16-mmol/L mag-
nesium ion, or both on sodium nitroprusside-induced re-
laxation (group II). SNP caused marked vasorelaxation in
a concentration-dependent manner, and full relaxation
(100%) occurred at 4 log mol/L. Incubation with either
20-mmol/L potassium ion (subgroup IIb), 16-mmol/L mag-
nesium ion (subgroup IIc), or 20-mmol/L potassium ion
plus 16-mmol/L magnesium ion (subgroup IId) did not alter
the SNP-induced relaxation (97.9%  0.9% in subgroup
IIb, 100%  0% in subgroup IIc, and 99.2%  0.8% in
subgroup IId, P  .05; Figure 3, B). In addition, there were
no differences in EC50 among these 4 subgroups.
Electrophysiologic Studies
Membrane potential during incubation. During incuba-
tion, the membrane potential was significantly depolarized
by 20-mmol/L potassium ion (39.7  1.5 vs 60.1  0.5
mV, P  .001). In contrast, incubation with 16-mmol/L
magnesium ion hyperpolarized the membrane potential
from 60.4  1.5 to 63.3  1.6 mV (P  .001). Inter-
estingly, incubation with 20-mmol/L potassium ion plus
16-mmol/L magnesium ion partially depolarized the mem-
brane potential (49.0  1.4 vs 60.1  1.5 mV, P 
.001), and the magnitude of the depolarization was signifi-
cantly less than that in the subgroup IVa (P .01, Figure 5).
During the washout period, the membrane potential re-
mained slightly higher (in subgroup IVa, Figure 6, A) or
returned to the previous level (in subgroups IVb and IVc,
Figure 6, B and C).
Bradykinin-induced hyperpolarization. Bradykinin (10
to 6.5 log mol/L) induced a concentration-dependent hy-
perpolarization in the porcine coronary artery. After super-
fusion with 20-mmol/L potassium ion for 1 hour (subgroup
IVa), the bradykinin-induced hyperpolarization was re-
duced (Figure 6, A). The maximal change was from
72.0  1.5 mV to 61.7  1.5 mV (n  7, P  .01). In
contrast, superfusion with magnesium ion (subgroup IVb)
did not alter the hyperpolarization (Figure 6, B). When the
superfusion was 20-mmol/L potassium ion plus 16-mmol/L
magnesium ion (subgroup IVc), the hyperpolarization was
significantly reduced relative to the control value (68.0 
2.5 mV vs 72.5  1.5 mV, n  6, P  .05; Figure 6, C).
However, compared with superfusion with potassium ion 20
mmol/L alone, the change of the membrane potential was
significantly recovered (10.0  1.0 vs. 3.3  0.8 mV, n 
7, P  .01) (Figure 6, D). Figure 5, D, also shows the
comparison of the magnitude of the change of membrane
potential in response to bradykinin among the subgroups of
group IV. Potassium ion greatly reduced the magnitude of
bradykinin-induced hyperpolarization of the membrane po-
tential, whereas magnesium ion did not. In the 8 arteries
TABLE 1. Maximal relaxation and EC50 values for bradykinin in the presence of indomethacin (7 mol/L), L-NNA (300
mol/L), and oxyhemoglobin (20 mol/L) in porcine coronary microarteries exposed for 1 hour to Krebs solution (control,
subgroup Ia), 20-mmol/L potassium ion (subgroup Ib), 16-mmol/L magnesium ion (subgroup Ic), or 20-mmol/L potassium ion
plus 16-mmol/L magnesium ion (subgroup Id)
Maximal relaxation (%) P value EC50 (log mol/L) P value
Subgroup Ia (control) 86.0 5.3 7.85 0.17
Subgroup Ib 35.0 4.9 .001 7.36 0.69* .529
Subgroup Ic 72.4 4.0 .243 7.70 0.24 .630
Subgroup Id 51.9 4.0 .001 7.22 0.24* .052
P values are versus control subgroup according to unpaired t test.
*In 3 of 8 rings, the EC50 was so high that could not be calculated from the curve-fitting equation (see Methods section). This actually implies a significant
difference of the EC50 from the control value.
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with the endothelium denuded, the bradykinin-induced hy-
perpolarization was abolished.
Discussion
This study has demonstrated for the first time that magne-
sium ion alone preserves EDHF-mediated relaxation and
hyperpolarization in porcine coronary arteries, that magne-
sium ion added to hyperkalemic cardioplegic solutions re-
stores EDHF-mediated relaxation and hyperpolarization,
and that the mechanism of the protective effect of magne-
sium ion is related to the preservation of the membrane
hyperpolarization and the reversal of the potassium ion-
induced depolarization of smooth muscle cells.
Coronary Tone During Incubation With Magnesium
Ion
In this study, the coronary microarterial tone increased
when the vessel was incubated with 20-mmol/L potassium
ion, a well-known phenomenon. We previously demon-
strated that the coronary tone remains almost without
change when the artery is incubated with St Thomas Hos-
pital cardioplegic solution, which also contains 20-mmol/L
potassium ion. The difference between the effects of these
Figure 3. Concentration-relaxation curves for bradykinin (A, group
I) and SNP (B, group II) in U46619-precontracted porcine coronary
microarteries. Bradykinin-induced relaxation was performed
with presence of indomethacin (7 mol/L), l-NNA (300 mol/L),
and oxyhemoglobin (20 mol/L) after exposure to following so-
lutions for 1 hour: subgroup Ia or IIa (control, filled circles), Krebs
solution; subgroup Ib or IIb (open circles), solution containing
20-mmol/L potassium ion; subgroup Ic or IIc (filled squares),
solution containing 16-mmol/L magnesium ion; and subgroup Id or
IId (open squares), solution containing 20-mmol/L potassium ion
plus 16-mmol/L magnesium ion. Four rings taken from same
microartery were allocated in four chambers of myograph; n  8
in each subgroup. Asterisk indicates P < .05 compared with
control subgroup by ANOVA and Scheffe´ F test; double asterisk
indicates P < .01.
Figure 4. Concentration-relaxation curves for bradykinin (group
III) in U46619-precontracted porcine coronary microarteries with
presence of indomethacin (7 mol/L), l-NNA (300 mol/L), and
oxyhemoglobin (20 mol/L) after exposure to following solutions
for 1 hour followed by 45-minute washout: subgroup IIIa (control,
filled circles), Krebs solution; subgroup IIIb (open circles), solu-
tion containing 20-mmol/L potassium ion; subgroup IIIc (filled
squares), solution containing 16-mmol/L magnesium ion; and sub-
group IIId (open squares), solution containing 20-mmol/L potas-
sium ion plus 16-mmol/L magnesium ion. Four rings taken from
same microartery were allocated in four chambers of myograph;
n  8 in each subgroup.
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two solutions is obviously related to other components in
the St Thomas Hospital solution, and we therefore became
interested in investigating the effects of another main cation
contained in St Thomas Hospital cardioplegic solution, 16-
mmol/L magnesium ion. The effects of magnesium ion on
the vascular tone may be 2-fold, on the resting force and on
contracted vessels.
The inhibitory effect of magnesium ion on the potassium
ion–induced increase in tone is clearly shown in Figure 1.
Compared with the marked increase in tone induced by
20-mmol/L potassium ion, addition of 16-mmol/L magne-
sium ion completely inhibited the potassium-induced con-
traction. When the coronary artery was incubated with 16-
mmol/L magnesium ion alone, the tone was slightly reduced
relative to the control value. Thus in the coronary arteries in
both resting and contracted states, the effect of 16-mmol-L
magnesium ion is to reduce the tone.
It has been reported that the effects of magnesium ion on
the vasculature involve a few mechanisms. Nakajima and
associates19 reported that extracellular magnesium ion in-
hibits receptor-mediated nonselective cation current, which
may contribute to the relaxation effects in vascular smooth
muscle cells. Skajaa and colleagues20 demonstrated that
magnesium ion inhibits the vascular response to several
vasoconstrictors, such as potassium ion and prostaglandin
F2, through affecting transmembrane calcium influx and
interfering with intracellular calcium effects.20 Further, it
has been suggested that extracellular magnesium ion at low
concentrations (0.1-6 nmol/L) can promote relaxation by
endothelium-derived relaxing factor and nitric oxide21 and
by cyclo-oxygenase–dependent mechanisms, such as the
production of prostacyclin.22 Because the concentration of
magnesium ion was as high as 16 mmol/L, we believe that
the mechanism of its inhibitory effect on contraction was
related to the direct action on the vascular smooth muscle,
as mentioned previously.19,20
The Membrane Potential of the Smooth Muscle in the
Coronary Artery During Incubation with Magnesium
Ion
In the resting state, in contrast to potassium ion, magnesium
ion alone at the concentration in St Thomas Hospital cardiople-
gic solution (16 mmol/L) significantly decreased the mem-
brane potential (hyperpolarization; Figure 4). Further, the ad-
dition of magnesium ion to hyperkalemic solutions reduced the
depolarization caused by potassium ion alone (P  .008),
although the membrane potential was still partially depolarized
(Figure 4). These experiments clearly demonstrate that the
effect of magnesium ion is to reduce the membrane potential
either in the resting state or when the membrane is depolarized.
Combined with the findings in the force recording during
incubation that magnesium ion, either alone or added to the
potassium ion solution, slightly reduced the resting force (Fig-
ure 1), the results clearly show that the previously found reduction
of resting force during incubation with St Thomas Hospital
cardioplegic solution15 is most likely due to the magnesium ion
contained in this solution. In addition, these experiments dem-
onstrate that the mechanism of the reduced tone induced by
magnesium ion is due to its relaxation-linked membrane hy-
perpolarization of the coronary smooth muscle cell.
Effect of magnesium ion on U46619-Induced
Contraction
For similar reasons to those mentioned previously, the con-
traction induced by U46619 was significantly reduced in the
magnesium ion-treated arteries. Even when the dose of
U46619 was increased in an attempt to reach a similar extent
of contraction for the relaxation studies with bradykinin, the
contraction response to U46619 was still less than that in
other groups. This effect, however, almost disappeared after
washout for 45 minutes.
Effects and Mechanisms of Potassium Ion and
Magnesium Ion Action on Endothelium-Derived
Hyperpolarizing Factor–Related Relaxation and
Hyperpolarization
Effect of potassium ion on endothelium-derived hyper-
polarizing factor-related relaxation and hyperpolarization.
After incubation with 20-mmol/L potassium ion for 1 hour,
the EDHF-mediated relaxation and hyperpolarization in-
Figure 5. Mean membrane potential of smooth muscle cells of
porcine coronary arteries in presence of indomethacin (7 mol/L)
and l-NNA (300 mol/L) after superfusion for 1 hour with solution
containing 20-mmol/L potassium ion (subgroup IVa, n  7, K20),
solution containing 16-mmol/L magnesium ion (subgroup IVb, n
6 , Mg16), or solution containing 20-mmol/L potassium ion plus
16-mmol/L magnesium ion (subgroup IVc, n  6, K20Mg16).
Triple asterisk indicates P < .001 versus control subgroup (before
superfusion) by paired t test.
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duced by bradykinin were significantly reduced. These re-
sults are consistent with our previous studies, which dem-
onstrated that EDHF-mediated response was impaired by
hyperkalemia.6,8-10 The mechanism of the impairment may
involve prolonged membrane depolarization and altered ac-
tivity of the calcium-activated potassium channels.6,8 The
effect of 20-mmol/L potassium ion on the hyperpolarization
induced by bradykinin was demonstrated in this study. The
membrane potential was greatly increased (depolarization)
in the coronary artery and the bradykinin-induced hyperpo-
larization was also greatly reduced (Figure 5). The change
in this relaxation-linked hyperpolarization further reveals
the mechanism of the hyperkalemia-induced reduction of
the EDHF-mediated function.
Effect of magnesium ion on endothelium-derived hy-
perpolarizing factor-related relaxation and hyperpolariza-
tion. In contrast, incubation with magnesium ion did not
significantly alter either the relaxation or the hyperpolariza-
Figure 6. Membrane potential measurement of smooth muscle cells of porcine coronary arteries. Concentration-
response (membrane potential) curves for bradykinin (A-C) in presence of indomethacin (7 mol/L) and l-NNA (300
mol/L) after superfusion for 1 hour. A, Superfusion with solution containing 20-mmol/L potassium ion (subgroup
IVa, n  7, open circles). B, Superfusion with solution containing 16-mmol/L magnesium ion (subgroup IVb, n 
6, open circles). C, Superfusion with solution containing 20-mmol/L potassium ion plus 16 mmol/magnesium ion
(subgroup IVc, n  6, open circles). D, Change of membrane potential to bradykinin (6.5 log mol/L). Asterisk
indicates P < .05 vs control subgroup (before superfusion) by paired t test; double asterisk indicates P < .01;
double pound sign indicates p < .01 vs 20-mmol/L potassium by unpaired t test.
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tion induced by bradykinin (Figures 3 and 5, B). These
results clearly show that the addition of magnesium ion in a
physiologic solution completely preserves EDHF-mediated
endothelial function. This is already a favorable effect.
More important, addition of magnesium ion to a hyperkale-
mic cardioplegic solution can reduce the impairment of the
EDHF-mediated function. When the artery was incubated
with potassium ion plus magnesium ion, the bradykinin-
induced EDHF-mediated relaxation was partially preserved
relative to that in the arteries incubated with potassium ion
alone (Figure 3, A). This partial recovery in the EDHF-
mediated endothelial function was due to the protective
effect of magnesium ion on the EDHF function, because the
membrane hyperpolarization induced by bradykinin after
incubation with potassium ion plus magnesium ion was
significantly more than that in arteries incubated with po-
tassium ion alone (P  .01, Figure 6, A, C, and D). As
previously demonstrated, hyperkalemia impairs EDHF-
mediated relaxation by depolarizing the membrane and in-
hibiting the calcium-activated potassium channels.6,8-10
Taken together, the effects of potassium ion and magnesium
ion on the membrane potential result in a favorable effect of
magnesium ion when added to the hyperkalemic solution.
Figure 6 depicts the effects of both potassium ion and
magnesium ion on the membrane potential of the coronary
smooth muscle cell regarding the EDHF-mediated endothe-
lial function and shows the possible mechanisms of action.
This study therefore demonstrated that the restoration of
the relaxation-linked hyperpolarization of the membrane
potential of coronary smooth muscle cells by magnesium
ion is the mechanism of the protective effect of the EDHF-
mediated relaxation by magnesium ion. This finding further
supports the use of magnesium ion in cardioplegic solu-
tions.
Limitations of the Study
This study addressed an important consideration in car-
dioplegic arrest regarding the effect of magnesium ion.
However, the study was an in vitro experimental investiga-
tion. The effect of reduced sodium in the experiment (to
exclude the effect of changed osmolarity) is unknown. In
addition, the overall effect of the alteration of the EDHF-
mediated relaxation after cardioplegic arrest on the coronary
flow remains to be studied further.
Clinical Implications
Magnesium ion has been shown to have a cardioprotective
effect against ischemia-reperfusion injury.13,23-27 This study
demonstrated that magnesium ion alone completely pre-
serves EDHF-mediated endothelial function, and when
added to hyperkalemic cardioplegia it allows significant
recovery of the EDHF-mediated endothelial function im-
paired by the high potassium ion concentration. Therefore
this study provides strong evidence that supplementation of
magnesium ion in hyperkalemic cardioplegia is essential for
endothelial protection.
In conclusion, magnesium ion alone preserved EDHF-
mediated relaxation and hyperpolarization in porcine coro-
nary microarteries in vitro. When added to hyperkalemic
cardioplegia, magnesium ion significantly restored the
EDHF-mediated endothelial function impaired by hyperka-
lemia. The mechanism of the protective effect of magne-
sium ion is related to the preservation of the membrane
hyperpolarization and the reversal of the potassium ion-
induced depolarization of the smooth muscle cell. Thus this
study strongly supports the use of magnesium ion in car-
dioplegic solutions.
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